IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

CNS Drugs

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

5.69

h-Index

2022-2023

 122

Rank

2022-2023

 2173

SJR

2022-2023

 1.485

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title CNS Drugs
Abbreviation CNS Drugs
Publication Type Journal
Subject Area, Categories, Scope Neurology (clinical) (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)
h-index 122
Overall Rank/Ranking 2173
SCImago Journal Rank (SJR) 1.485
Impact Score 5.69
Publisher Adis International Ltd
Country United Kingdom
ISSN 11791934, 11727047
Best Quartile Q1
Coverage History 1994-2022




Aim and Scope


CNS Drugs is a one-stop shop for all important information about the drug treatment of psychiatric and neurological disorders. The journal takes a bench to bedside approach, covering topics from basic pharmacology and disease pathology to drugs in development and guidelines for clinical practice.

Each issue of CNS Drugs provides:
* current opinion/leading articles providing an overview of contentious or emerging issues
* definitive reviews on approaches to the management of neurological and psychiatric illnesses
* therapy in practice reviews providing practical recommendations for specific clinical situations


About CNS Drugs


CNS Drugs is a journal covering the technologies/fields/categories related to Neurology (clinical) (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1). It is published by Adis International Ltd. The overall rank of CNS Drugs is 2173. According to SCImago Journal Rank (SJR), this journal is ranked 1.485. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 122. The best quartile for this journal is Q1.

The ISSN of CNS Drugs journal is 11791934, 11727047. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. CNS Drugs is cited by a total of 1572 articles during the last 3 years (Preceding 2022).


CNS Drugs Impact IF 2022-2023


The Impact IF 2022 of CNS Drugs is 5.69, which is computed in 2023 as per its definition. CNS Drugs IF is decreased by a factor of 0.25 and approximate percentage change is -4.21% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

CNS Drugs Impact IF 2023 Prediction


Impact IF 2022 of CNS Drugs is 5.69. If the same downward trend persists, Impact IF may fall in 2023 as well.


Impact IF Trend


Year wise Impact IF of CNS Drugs. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 5.69
2021 5.94
2020 4.66
2019 4.65
2018 4.39
2017 4.61
2016 5.11
2015 5.60
2014 5.77

CNS Drugs h-index


  Table Setting

CNS Drugs has an h-index of 122. It means 122 articles of this journal have more than 122 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




CNS Drugs ISSN


The ISSN of CNS Drugs is 11791934, 11727047. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

CNS Drugs Rank and SCImago Journal Rank (SJR)


The overall rank of CNS Drugs is 2173. According to SCImago Journal Rank (SJR), this journal is ranked 1.485. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of CNS Drugs by Year


Year SJR
2023/2024 Coming Soon
2022 1.485
2021 1.263
2020 1.565
2019 1.522
2018 1.553
2017 1.635
2016 1.819
2015 1.767
2014 1.922

Ranking of CNS Drugs by Year


Year Ranking
2023/2024 Coming Soon
2022 2173
2021 2809
2020 2109
2019 2171
2018 2110
2017 1970
2016 1674
2015 1798
2014 1500

CNS Drugs Publisher


Table Setting

CNS Drugs is published by Adis International Ltd. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 1994-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of CNS Drugs is CNS Drugs. This abbreviation ('CNS Drugs') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in CNS Drugs


If your research field is/are related to Neurology (clinical) (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the CNS Drugs?

CNS Drugs latest impact IF is 5.69. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 5.94 (2021) and 4.39 (2018), respectively, in the last 9 years. Moreover, its average IS is 5.16 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the CNS Drugs?

The CNS Drugs has an SJR (SCImago Journal Rank) of 1.485, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 1.922 in 2014 and the lowest being 1.263 in 2021. Furthermore, the average SJR of the CNS Drugs over the previous 9-year period stands at 5.16.


What's the latest h-index of the CNS Drugs?

The latest h-index of the CNS Drugs is 122.


Who's the publisher of the CNS Drugs?

The CNS Drugs is published by the Adis International Ltd, with its country of publication being the United Kingdom.


What's the current ranking of the CNS Drugs?

The CNS Drugs is currently ranked 2173 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 1500 in 2014 and its lowest position of 2809 in 2021.


What's the abbreviation or short name for the CNS Drugs?

The standard ISO4 abbreviation for the CNS Drugs is CNS Drugs.


Is the "CNS Drugs" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

CNS Drugs is classified as a journal that the Adis International Ltd publishes.


What's the scope or major areas of the CNS Drugs?

The CNS Drugs encompasses the following areas:

  • Neurology (clinical)
  • Pharmacology (medical)
  • Psychiatry and Mental Health

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the CNS Drugs?

The CNS Drugs is assigned the following International Standard Serial Numbers (ISSN): 11791934, 11727047.


What's the best quartile of the CNS Drugs?

The best quartile for the CNS Drugs is Q1 (2022).


What's the coverage history of the CNS Drugs?

The CNS Drugs coverage history can be summarized as follows: 1994-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Journal of Academic Ethics journal 8920 Springer Netherlands 26 2.28
Business Strategy Review journal 31512 Wiley-Blackwell Publishing Ltd 33 0.04
Air and Space Power Journal (discontinued) journal 28397 AU Press 9 0.20
International Journal of Research and Method in Education journal 5180 Taylor and Francis Ltd. 34 2.49
Studies in Continuing Education journal 6011 Routledge 38 2.81
Proceedings of the ACM SIGKDD International Conference on Knowledge Discovery and Data Mining conference and proceedings 4334 192 0.00
PLoS ONE journal 5108 Public Library of Science 404 3.75
Himalayan Geology journal 14451 Wadia Institute of Himalayan Geology 16 1.41
Nan fang yi ke da xue xue bao = Journal of Southern Medical University journal 18302 Nanfang Yi Ke Da Xue Xue Bao Bian ji Bu 23 0.89
Indian Journal of Rheumatology journal 18638 Wolters Kluwer Medknow Publications 15 0.44

Check complete list




Year wise Impact Score (IS) of CNS Drugs

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 5.69
2021 5.94
2020 4.66
2019 4.65
2018 4.39
2017 4.61
2016 5.11
2015 5.60
2014 5.77



Top Journals/Conferences in Neurology (clinical)

Lancet Neurology, The
Elsevier Ltd. | United Kingdom

JAMA Neurology
American Medical Association | United States

Nature Reviews Neurology
Nature Publishing Group | United Kingdom

Molecular Neurodegeneration
BioMed Central Ltd. | United Kingdom

Acta Neuropathologica
Springer Verlag | Germany

Neuro-Oncology
Oxford University Press | United Kingdom

Brain
Oxford University Press | United Kingdom

Annals of Neurology
John Wiley & Sons Inc. | United States

Alzheimer's and Dementia
John Wiley & Sons Inc. | United States

Journal of Neurology, Neurosurgery and Psychiatry
BMJ Publishing Group | United Kingdom

See All

Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United States

npj Vaccines
Nature Publishing Group | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

American Journal of Transplantation
Wiley-Blackwell Publishing Ltd | United Kingdom

Journal of Biomedical Science
BioMed Central Ltd. | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

Drugs
Adis International Ltd | United Kingdom

Rheumatology
Oxford University Press | United Kingdom

Acta Pharmacologica Sinica
Nature Publishing Group | United Kingdom

See All

Top Journals/Conferences in Psychiatry and Mental Health

World Psychiatry
Wiley-Blackwell | United States

Lancet Psychiatry,The
Elsevier Ltd. | United Kingdom

Annual Review of Clinical Psychology
Annual Reviews Inc. | United States

JAMA Psychiatry
American Medical Association | United States

Evidence-Based Mental Health
BMJ Publishing Group | United Kingdom

Psychotherapy and Psychosomatics
S. Karger AG | Switzerland

Clinical Psychology Review
Elsevier Inc. | United States

American Journal of Psychiatry
American Psychiatric Association | United States

Journal of the American Academy of Child and Adolescent Psychiatry
Elsevier Ltd. | United Kingdom

Lancet Healthy Longevity, The
Elsevier Ltd. | United Kingdom

See All